Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Testing effectiveness (Phase 2)WithdrawnNCT04105062What this trial is testingLS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryWho this might be right forPancreatic CancerLiver CancerGastric Cancer+2 more Washington University School of Medicine
Not applicableUnknownNCT04145973What this trial is testingEvaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After SurgeryWho this might be right forBreast Cancer Peking Union Medical College Hospital 200
Very early researchUnknownNCT05459441What this trial is testingEfficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal MetastasesWho this might be right forGliomaBrain Metastases Shanghai Pudong Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01283789What this trial is testingLapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Kansas Medical Center 23
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Not applicableLooking for participantsNCT04854213What this trial is testingPRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)Who this might be right forColorectal Cancer Metastatic National Cancer Institute, Naples 25
Testing effectiveness (Phase 2)Looking for participantsNCT06401824What this trial is testingSacituzumab Govitecan and Bevacizumab for NSCLC Brain MetastasesWho this might be right forNSCLC Stage IVBrain Metastases, Adult Maastricht University Medical Center 25
Not applicableUnknownNCT03175146What this trial is testingSee Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver SafelyWho this might be right forColonic NeoplasmsNeoplasm Metastasis AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Testing effectiveness (Phase 2)Study completedNCT00002842What this trial is testingLiver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00031278What this trial is testingSafety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast CancerWho this might be right forCarcinoma, Metastatic Breast Pfizer 12
Not applicableEnded earlyNCT02354326What this trial is testingDual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With CancerWho this might be right forMalignant NeoplasmMetastatic Malignant Neoplasm to the Bone Case Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Post-approval studies (Phase 4)Ended earlyNCT04031885What this trial is testingAbemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Eli Lilly and Company 4
Testing effectiveness (Phase 2)UnknownNCT02913417What this trial is testingYttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver MetastasesWho this might be right forUveal MelanomaHepatic Metastases David Minor, MD 26
Very early researchEnded earlyNCT00835679What this trial is testingCetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryWho this might be right forLiver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT06042946What this trial is testingMicrosurgical Resection of Intramedullary Spinal Cord MetastasesWho this might be right forSpinal Cord MetastasisSpinal Cord Tumor Malignant IntramedullaryFunctional Outcome+2 more Cantonal Hospital of St. Gallen 60
Large-scale testing (Phase 3)Ended earlyNCT00662688What this trial is testingChemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic CancerWho this might be right forChemotherapeutic Agent ToxicityPancreatic CancerThromboembolism GERCOR - Multidisciplinary Oncology Cooperative Group 42
Large-scale testing (Phase 3)Ended earlyNCT05223673What this trial is testingPhase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Institut de Recherches Internationales Servier 7